Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.878 USD | +0.23% | +0.23% | +4.52% |
Apr. 24 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
Apr. 24 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
Financials (USD)
Sales 2022 | 218M | Sales 2023 | 136M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2022 | 182M | Net income 2023 | 108M | EV / Sales 2022 | 5.19 x |
Net cash position 2022 | 121M | Net cash position 2023 | 135M | EV / Sales 2023 | 7.07 x |
P/E ratio 2022 |
7.11
x | P/E ratio 2023 |
10.1
x | Employees | - |
Yield 2022 |
7.37% | Yield 2023 |
8.33% | Free-Float | 88.56% |
1 day | +0.23% | ||
1 week | +0.23% | ||
Current month | +0.92% | ||
1 month | -2.23% | ||
3 months | -6.60% | ||
6 months | +5.28% | ||
Current year | +4.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hyman
CHM | Chairman | 67 | 17-02-26 |
Duncan Budge
BRD | Director/Board Member | 68 | - |
Director/Board Member | - | 18-12-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.878 | +0.23% | 1,651,357 |
24-04-25 | 0.876 | -0.23% | 1,232,752 |
24-04-24 | 0.878 | +0.23% | 5,369,025 |
24-04-23 | 0.876 | 0.00% | 2,292,315 |
24-04-22 | 0.876 | 0.00% | 1,393,094 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.52% | 1.08B | |
+3.74% | 12.52B | |
+5.50% | 8.84B | |
-3.20% | 5.39B | |
+5.63% | 5.16B | |
+2.44% | 5.11B | |
+14.36% | 4.51B | |
+16.67% | 4.44B | |
+1.53% | 4.01B | |
+1.56% | 3.75B |
- Stock Market
- Equities
- BPCP Stock